INBX

Inhibrx (INBX)

Inhibrx Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:INBX

1 2 3 4 5 6 7 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/22	22:54	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:INBX	Inhibrx Inc
2024/05/21	10:48	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:INBX	Inhibrx Inc
2024/05/18	06:29	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INBX	Inhibrx Inc
2024/05/18	05:25	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:INBX	Inhibrx Inc
2024/05/11	07:36	PR Newswire (US)	Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-Off	NASDAQ:INBX	Inhibrx Inc
2024/05/10	05:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INBX	Inhibrx Inc
2024/05/09	05:57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INBX	Inhibrx Inc
2024/05/09	05:42	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INBX	Inhibrx Inc
2024/05/09	05:37	PR Newswire (US)	Inhibrx, Inc. Announces Record Date and Expected Distribution Time for Anticipated Spin-Off and the Expected Merger Effective Time for Anticipated Merger	NASDAQ:INBX	Inhibrx Inc
2024/05/07	06:16	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:INBX	Inhibrx Inc
2024/03/12	05:26	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:INBX	Inhibrx Inc
2024/03/09	06:08	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:INBX	Inhibrx Inc
2024/03/09	05:28	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:INBX	Inhibrx Inc
2024/03/07	06:41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INBX	Inhibrx Inc
2024/03/06	04:58	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:INBX	Inhibrx Inc
2024/03/05	08:26	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:INBX	Inhibrx Inc
2024/03/01	07:26	Edgar (US Regulatory)	Form PREM14A - Preliminary proxy statements relating to merger or acquisition	NASDAQ:INBX	Inhibrx Inc
2024/02/28	23:15	PR Newswire (US)	Inhibrx Reports Fourth Quarter and Fiscal Year 2023 Financial Results	NASDAQ:INBX	Inhibrx Inc
2024/02/28	23:12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INBX	Inhibrx Inc
2024/02/28	23:10	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:INBX	Inhibrx Inc
2024/02/15	06:12	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:INBX	Inhibrx Inc
2024/02/07	06:30	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:INBX	Inhibrx Inc
2024/01/27	02:12	PR Newswire (US)	Kuehn Law Encourages DOC, BATL, KAMN, and INBX Investors to Contact Law Firm	NASDAQ:INBX	Inhibrx Inc
2024/01/24	07:25	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:INBX	Inhibrx Inc
2024/01/23	20:38	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:INBX	Inhibrx Inc
2024/01/23	20:35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INBX	Inhibrx Inc
2024/01/23	20:05	Dow Jones News	Sanofi to Buy Assets From Inhibrx in Deal Valued at Up to $2.2 Billion -- Update	NASDAQ:INBX	Inhibrx Inc
2024/01/23	19:40	IH Market News	Wall Street Highlights: Vroom Shuts Down Online Car Sales, Ericsson Warns of Decline Outside China, and More	NASDAQ:INBX	Inhibrx Inc
2024/01/23	15:00	PR Newswire (US)	Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B	NASDAQ:INBX	Inhibrx Inc
2023/11/10	06:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INBX	Inhibrx Inc